Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2012 Jul;96(1):142-3.
doi: 10.1007/s12185-012-1113-y. Epub 2012 May 26.

Clinical relevance of the association of interferon alfa to imatinib in chronic myeloid leukemia therapy

Fabio Stagno, Paolo Vigneri, Francesco Di Raimondo
Comment

Clinical relevance of the association of interferon alfa to imatinib in chronic myeloid leukemia therapy

Fabio Stagno et al. Int J Hematol. 2012 Jul.
No abstract available

PubMed Disclaimer

Comment on

  • Imatinib plus peginterferon alfa-2a in chronic myeloid leukemia.
    Preudhomme C, Guilhot J, Nicolini FE, Guerci-Bresler A, Rigal-Huguet F, Maloisel F, Coiteux V, Gardembas M, Berthou C, Vekhoff A, Rea D, Jourdan E, Allard C, Delmer A, Rousselot P, Legros L, Berger M, Corm S, Etienne G, Roche-Lestienne C, Eclache V, Mahon FX, Guilhot F; SPIRIT Investigators; France Intergroupe des Leucémies Myéloïdes Chroniques (Fi-LMC). Preudhomme C, et al. N Engl J Med. 2010 Dec 23;363(26):2511-21. doi: 10.1056/NEJMoa1004095. N Engl J Med. 2010. PMID: 21175313 Clinical Trial.
  • Combination of pegylated IFN-α2b with imatinib increases molecular response rates in patients with low- or intermediate-risk chronic myeloid leukemia.
    Simonsson B, Gedde-Dahl T, Markevärn B, Remes K, Stentoft J, Almqvist A, Björeman M, Flogegård M, Koskenvesa P, Lindblom A, Malm C, Mustjoki S, Myhr-Eriksson K, Ohm L, Räsänen A, Sinisalo M, Själander A, Strömberg U, Bjerrum OW, Ehrencrona H, Gruber F, Kairisto V, Olsson K, Sandin F, Nagler A, Nielsen JL, Hjorth-Hansen H, Porkka K; Nordic CML Study Group. Simonsson B, et al. Blood. 2011 Sep 22;118(12):3228-35. doi: 10.1182/blood-2011-02-336685. Epub 2011 Jun 17. Blood. 2011. PMID: 21685374 Clinical Trial.

References

    1. N Engl J Med. 1997 Jul 24;337(4):223-9 - PubMed
    1. Blood. 2011 May 5;117(18):4706-15 - PubMed
    1. N Engl J Med. 2010 Jun 17;362(24):2251-9 - PubMed
    1. N Engl J Med. 2010 Jun 17;362(24):2260-70 - PubMed
    1. J Clin Oncol. 2011 Apr 20;29(12):1634-42 - PubMed

LinkOut - more resources